NM_001972.4(ELANE):c.129C>G (p.Phe43Leu) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 1, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003801390.2

Allele description [Variation Report for NM_001972.4(ELANE):c.129C>G (p.Phe43Leu)]

NM_001972.4(ELANE):c.129C>G (p.Phe43Leu)

Gene:
ELANE:elastase, neutrophil expressed [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.3
Genomic location:
Preferred name:
NM_001972.4(ELANE):c.129C>G (p.Phe43Leu)
HGVS:
  • NC_000019.10:g.852937C>G
  • NG_009627.1:g.5647C>G
  • NM_001972.4:c.129C>GMANE SELECT
  • NP_001963.1:p.Phe43Leu
  • NP_001963.1:p.Phe43Leu
  • LRG_57t1:c.129C>G
  • LRG_57:g.5647C>G
  • LRG_57p1:p.Phe43Leu
  • NC_000019.9:g.852937C>G
  • NM_001972.2:c.129C>G
Protein change:
F43L
Molecular consequence:
  • NM_001972.4:c.129C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cyclical neutropenia
Synonyms:
Cyclic hematopoiesis
Identifiers:
MONDO: MONDO:0008090; MedGen: C0221023; Orphanet: 2686; OMIM: 162800; Human Phenotype Ontology: HP:0040289
Name:
Neutropenia, severe congenital, 1, autosomal dominant
Identifiers:
MONDO: MONDO:0042490; MedGen: C1859966; OMIM: 202700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004594269Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 1, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register.

Bellanné-Chantelot C, Clauin S, Leblanc T, Cassinat B, Rodrigues-Lima F, Beaufils S, Vaury C, Barkaoui M, Fenneteau O, Maier-Redelsperger M, Chomienne C, Donadieu J.

Blood. 2004 Jun 1;103(11):4119-25. Epub 2004 Feb 12.

PubMed [citation]
PMID:
14962902

The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia.

Germeshausen M, Deerberg S, Peter Y, Reimer C, Kratz CP, Ballmaier M.

Hum Mutat. 2013 Jun;34(6):905-14. doi: 10.1002/humu.22308. Epub 2013 Apr 2.

PubMed [citation]
PMID:
23463630
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004594269.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 43 of the ELANE protein (p.Phe43Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with severe congenital neutropenia or cyclic neutropenia (PMID: 14962902, 23463630, 34340247; Invitae). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ELANE protein function. This variant disrupts the p.Phe43 amino acid residue in ELANE. Other variant(s) that disrupt this residue have been observed in individuals with ELANE-related conditions (PMID: 31321910), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024